NCT04943575 - Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI) | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

January 30, 2022

Study Completion Date

January 30, 2022

Conditions

Common Cold

Interventions

DIETARY_SUPPLEMENT

EZC Pak

After the onset of common cold symptoms, participants will take one pill (EZC Pak) each day for a period of 5 days.

DIETARY_SUPPLEMENT

EZC Pak +D

After the onset of common cold symptoms, participants will take one pill (EZC Pak +D) each day for a period of 5 days.

DIETARY_SUPPLEMENT

Placebo

After the onset of common cold symptoms, participants will take one pill (Placebo) each day for a period of 5 days.

Trial Locations (1)

Citruslabs, Santa Monica